Compare SOHU & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOHU | TMCI |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.6M | 292.0M |
| IPO Year | 2018 | 2021 |
| Metric | SOHU | TMCI |
|---|---|---|
| Price | $12.54 | $4.10 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | ★ $19.50 | $5.50 |
| AVG Volume (30 Days) | 84.9K | ★ 217.5K |
| Earning Date | 11-16-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $212,690,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.46 | $6.88 |
| P/E Ratio | $1.16 | ★ N/A |
| Revenue Growth | N/A | ★ 1.59 |
| 52 Week Low | $11.61 | $1.17 |
| 52 Week High | $17.30 | $7.08 |
| Indicator | SOHU | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 39.14 | 43.08 |
| Support Level | $12.41 | $3.84 |
| Resistance Level | $13.71 | $4.67 |
| Average True Range (ATR) | 0.36 | 0.24 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 25.51 | 39.96 |
Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. Sohu is an online media content and services provider. Through its social features, Sohu also enables users to generate and distribute content, as well as interact with each other on a platform. Changyou is an online game developer and operator. It generates maximum revenue from the Changyou segment.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.